Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
- PMID: 23962875
- DOI: 10.4161/auto.25664
Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
Abstract
Although suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, has been used in clinical trials for cancer therapies, its pharmacological effects occur through a poorly understood mechanism. Here, we report that SAHA specifically triggers autophagy and reduces cell viability via promotion of apoptosis in the late phase of glioblastoma stem cells (GSCs). Using a cell line cultured from a glioblastoma biopsy, we investigated the properties and effects of GSCs under SAHA treatment in vitro. In vivo xenograft assays revealed that SAHA effectively caused tumor growth slowdown and the induction of autophagy. SAHA was sufficient to increase formation of intracellular acidic vesicle organelles, recruitment of LC3-II to the autophagosomes, potentiation of BECN1 protein levels and reduced SQSTM1 levels. We determined that SAHA triggered autophagy through the downregulation of AKT-MTOR signaling, a major suppressive cascade of autophagy. Interestingly, upon depletion or pharmacological inhibition of autophagy, SAHA facilitates apoptosis and results in cell death at the early phase, suggesting that SAHA-induced autophagy functions probably act as a prosurvival mechanism. Furthermore, our results also indicated that the inhibition of SAHA-induced autophagy using chloroquine has synergistic effects that further increase apoptosis. Moreover, we found that a reduced dose of SAHA functioned as a potent modulator of differentiation and senescence. Taken together, our results provide a new perspective on the treatment of GSCs, indicating that SAHA is a promising agent for targeting GSCs through the induction of autophagy.
Keywords: AKT-MTOR signaling; SAHA; autophagy; chloroquine; glioblastoma stem cells.
Similar articles
-
Suberoylanilide hydroxamic acid represses glioma stem-like cells.J Biomed Sci. 2016 Nov 18;23(1):81. doi: 10.1186/s12929-016-0296-6. J Biomed Sci. 2016. PMID: 27863490 Free PMC article.
-
Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells.Autophagy. 2010 Aug;6(6):711-24. doi: 10.4161/auto.6.6.12397. Epub 2010 Aug 17. Autophagy. 2010. PMID: 20543569
-
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.Cancer Chemother Pharmacol. 2010 Nov;66(6):1131-40. doi: 10.1007/s00280-010-1455-1. Epub 2010 Sep 14. Cancer Chemother Pharmacol. 2010. PMID: 20838997
-
Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53.Int J Mol Sci. 2017 Aug 31;18(9):1883. doi: 10.3390/ijms18091883. Int J Mol Sci. 2017. PMID: 30563957 Free PMC article. Review.
-
The Multi-Faceted Effect of Curcumin in Glioblastoma from Rescuing Cell Clearance to Autophagy-Independent Effects.Molecules. 2020 Oct 20;25(20):4839. doi: 10.3390/molecules25204839. Molecules. 2020. PMID: 33092261 Free PMC article. Review.
Cited by
-
Targeting Tumorigenicity of Breast Cancer Stem Cells Using SAHA/Wnt-b Catenin Antagonist Loaded Onto Protein Corona of Gold Nanoparticles.Int J Nanomedicine. 2020 Jun 11;15:4063-4078. doi: 10.2147/IJN.S234636. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32606664 Free PMC article.
-
Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma.Cell Death Dis. 2020 Jun 2;11(6):417. doi: 10.1038/s41419-020-2586-x. Cell Death Dis. 2020. PMID: 32488056 Free PMC article.
-
Emerging targets for glioblastoma stem cell therapy.J Biomed Res. 2016 Jan;30(1):19-31. doi: 10.7555/JBR.30.20150100. Epub 2015 Sep 20. J Biomed Res. 2016. PMID: 26616589 Free PMC article.
-
Nutrient starvation induces apoptosis and autophagy in C6 glioma stem-like cells.Heliyon. 2021 Feb 26;7(2):e06352. doi: 10.1016/j.heliyon.2021.e06352. eCollection 2021 Feb. Heliyon. 2021. PMID: 33718649 Free PMC article.
-
Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma.Apoptosis. 2018 Dec;23(11-12):563-575. doi: 10.1007/s10495-018-1480-9. Apoptosis. 2018. PMID: 30171377 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous